Luís Lima - Concepedia

Author

Luís Lima

Instituto Português de Oncologia Francisco Gentil ORCID

Also Known As

F Reis, L Lima, L. Costa de Oliveira Lima, L. Lima, LARISSA ELLEN MOREIRA DE LIMA, LUCIANE DA SILVA LIMA, Lariane Joana Bezerra Lima, Larissa Rodrigues Zanela Lima, Laura Costa de Oliveira Lima, Leandra de Oliveira Lima

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Instituto Português de Oncologia Francisco Gentil Universidade do Porto Fernando Pessoa University IPO Porto i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto

About

Luís Lima is an author at Instituto Português de Oncologia Francisco Gentil specializing in medicine, cancer research, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.4K
2	Engineering	4	4	124
3	Natural Sciences	3	3	157
4	Public Health	1	1	17
5	Biochemistry	1	1	34

Luís Lima

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Frequency of TERT promoter mutations in human cancers João Vinagre, Ana Paula de Almeida, Helena Pópulo, Nature Communications Somatic VariantTert Promoter MutationsPathologyCancer GenomicsCancer Genetics	2013	882
Overexpression of tumour‐ssociated carbohydrate antigen sialyl‐Tn in advanced bladder tumours José Alexandre Ferreira, Paula A. Videira, Luís Lima, Molecular Oncology	2013	105
The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure Luís Lima, Daniela Oliveira, Ana Tavares, Urologic Oncology Seminars and Original Investigations	2013	90
Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics Céu Costa, Sofia Pereira, Luís Lima, PLoS ONE UrologyAbnormal Protein GlycosylationMtor-pathway Inhibitor SirolimusGenitourinary CancerPi3k/akt/mtor Pathway Intermediates	2015	73
Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein<i>O</i>-glycosylation extension Andreia Peixoto, Elisabete Fernandes, Cristiana Gaiteiro, Oncotarget Malignant NatureGlycobiologyPathologyBladder Cancer CellsCancer Biology	2016	70
Targeted <i>O</i>‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours Sofia Cotton, Rita Azevedo, Cristiana Gaiteiro, Molecular Oncology	2017	63
CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications Rita Azevedo, Cristiana Gaiteiro, Andreia Peixoto, Clinical Proteomics Cd44 RoleCd44 NomenclatureGlycobiologyPathologyMolecular Biology	2018	53
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids Liliana R. Loureiro, Diana P. Sousa, Dylan Ferreira, Scientific Reports	2018	53
Profiling DNA mutation patterns by SERS fingerprinting for supervised cancer classification Lei Wu, Alexandra Teixeira, Alejandro Garrido‐Maestu, Biosensors and Bioelectronics Functional GenomicsEngineeringSomatic VariantTumor HeterogeneityMedicine	2020	50
The role of functional polymorphisms in immune response genes as biomarkers of bacille <scp>C</scp> almette‐ <scp>G</scp> uérin ( <scp>BCG</scp> ) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a <scp>S</scp> outhern <scp>E</scp> urope population Luís Lima, Daniela Oliveira, José Alexandre Ferreira, British Journal of Urology	2014	49

Page 1